Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer.

Purpose: We evaluated whether 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) and 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) positron emission tomography (PET) could be used as imaging biomarkers of platinum resensitization in ovarian cancer.Procedures: Paired platinum-sensitive and platinum-res...

Descripción completa

Detalles Bibliográficos
Publicado en:Molecular Imaging & Biology Vol. 14; no. 6; pp. 753 - 762
Autores principales: Perumal M, Stronach EA, Gabra H, Aboagye EO, Perumal, Meg, Stronach, Euan A, Gabra, Hani, Aboagye, Eric O
Formato: research Journal Article
Publicado: Springer Nature Dec2012
Acceso en línea:Ver este registro en EBSCOhost